Total Payments
$711.22
2024 Payments
$343.88
Companies
12
Transactions
40
Medicare Patients
1,847
Medicare Billing
$118,909
Payment Breakdown by Category
Food & Beverage$711.22 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $711.22 | 40 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $280.50 | 14 | $0 (2024) |
| Lilly USA, LLC | $186.57 | 11 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $50.51 | 3 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $39.29 | 2 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $32.71 | 2 | $0 (2024) |
| Amgen Inc. | $27.12 | 2 | $0 (2023) |
| Lundbeck LLC | $18.00 | 1 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $17.09 | 1 | $0 (2023) |
| Acceleron Pharma, Inc. | $15.70 | 1 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $15.17 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $343.88 | 19 | Novo Nordisk Inc ($198.45) |
| 2023 | $323.92 | 18 | Lilly USA, LLC ($111.52) |
| 2022 | $13.36 | 1 | Lilly USA, LLC ($13.36) |
| 2021 | $30.06 | 2 | Acceleron Pharma, Inc. ($15.70) |
All Payment Transactions
40 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Respiratory | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Respiratory | ||||||
| 09/23/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Diabetes | ||||||
| 08/27/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: Diabetes | ||||||
| 08/20/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Diabetes | ||||||
| 08/02/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.00 | General |
| Category: PSYCHIATRY | ||||||
| 07/31/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: Respiratory | ||||||
| 07/26/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: Diabetes | ||||||
| 06/25/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: Diabetes | ||||||
| 05/28/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Diabetes | ||||||
| 05/20/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.37 | General |
| 04/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: Diabetes | ||||||
| 04/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: Diabetes | ||||||
| 04/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: Cardio-renal | ||||||
| 03/21/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Oncology | ||||||
| 03/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.47 | General |
| Category: Diabetes | ||||||
| 02/20/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Diabetes | ||||||
| 01/23/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.05 | General |
| Category: Diabetes | ||||||
| 11/27/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: Inflammation | ||||||
| 11/21/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Diabetes | ||||||
| 11/14/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: Diabetes | ||||||
| 10/18/2023 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: NEUROLOGY | ||||||
| 10/09/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: UROLOGY | ||||||
| 10/03/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 597 | 837 | $114,100 | $23,466 |
| 2022 | 15 | 639 | 906 | $154,973 | $46,135 |
| 2021 | 7 | 309 | 421 | $63,754 | $21,749 |
| 2020 | 5 | 302 | 507 | $81,768 | $27,559 |
Total Patients
1,847
Total Services
2,671
Medicare Billing
$118,909
Procedure Codes
38
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 226 | 281 | $48,842 | $13,342 | 27.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 50 | 51 | $12,516 | $2,355 | 18.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 15 | 15 | $3,735 | $1,564 | 41.9% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Office | 2023 | 60 | 67 | $5,561 | $1,334 | 24.0% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 24 | 24 | $2,472 | $1,207 | 48.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 21 | 21 | $4,725 | $1,176 | 24.9% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 28 | 31 | $4,061 | $826.15 | 20.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 13 | $4,485 | $808.18 | 18.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 64 | 68 | $3,511 | $532.69 | 15.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 55 | 220 | $23,864 | $164.70 | 0.7% |
| 81002 | Urinalysis, manual test | Office | 2023 | 41 | 46 | $328.00 | $156.86 | 47.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 147 | 204 | $35,292 | $10,080 | 28.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 104 | 129 | $31,476 | $9,664 | 30.7% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 96 | 204 | $26,724 | $8,214 | 30.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 66 | 72 | $24,840 | $6,891 | 27.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 25 | 25 | $6,225 | $2,591 | 41.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 19 | 19 | $8,018 | $2,314 | 28.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 25 | 25 | $4,075 | $1,649 | 40.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 26 | 33 | $4,521 | $1,281 | 28.3% |
| 99307 | Follow-up nursing facility visit per day, typically 10 minutes | Office | 2022 | 38 | 47 | $3,901 | $1,167 | 29.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 11 | 11 | $2,849 | $962.94 | 33.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $4,147 | $943.47 | 22.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 17 | 18 | $486.00 | $126.71 | 26.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 15 | 15 | $405.00 | $126.16 | 31.2% |
| 81002 | Urinalysis, manual test | Office | 2022 | 20 | 22 | $220.00 | $75.40 | 34.3% |
About Haley Mitchell
Haley Mitchell is a Registered Nurse healthcare provider based in Ada, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/23/2019. The National Provider Identifier (NPI) number assigned to this provider is 1033760970.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Haley Mitchell has received a total of $711.22 in payments from pharmaceutical and medical device companies, with $343.88 received in 2024. These payments were reported across 40 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($711.22).
As a Medicare-enrolled provider, Mitchell has provided services to 1,847 Medicare beneficiaries, totaling 2,671 services with total Medicare billing of $118,909. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Ad
Practice Information
- Specialty Registered Nurse
- Other Specialties Family, Nurse Practitioner
- Location Ada, OK
- Active Since 09/23/2019
- Last Updated 04/10/2020
- Taxonomy Code 163W00000X
- Entity Type Individual
- NPI Number 1033760970
Products in Payments
- Rybelsus (Drug) $183.14
- Ozempic (Drug) $83.99
- MOUNJARO (Drug) $83.81
- TRULICITY (Drug) $75.04
- NUEDEXTA (Drug) $39.29
- Kerendia (Drug) $32.71
- AIRSUPRA (Drug) $32.56
- REXULTI (Drug) $18.00
- BREZTRI (Drug) $17.95
- GEMTESA (Drug) $17.09
- Reblozyl (Drug) $15.70
- LEQVIO (Drug) $15.17
- Cologuard Collection Kit (Device) $14.73
- EMGALITY (Drug) $14.36
- EVENITY (Biological) $14.11
- TRELEGY ELLIPTA (Drug) $13.83
- JARDIANCE (Drug) $13.36
- Otezla (Drug) $13.01
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Ada
Susan Kibe, Aprn, APRN
Registered Nurse — Payments: $1,155
Registered Nurse $1,155
Lindsay Kates, Aprn-Cnp, APRN-CNP
Registered Nurse — Payments: $969.80
Registered Nurse $969.80
Robin Anderson, Aprn, APRN
Registered Nurse — Payments: $422.64
Registered Nurse $422.64
Edward Gradman
Registered Nurse — Payments: $280.94
Registered Nurse $280.94
Mr. Jeffrey Mcphail, Aprn-Cns, APRN-CNS
Registered Nurse
Registered Nurse
Ms. Sheryll Philby, R.n, R.N
Registered Nurse
Registered Nurse